Sabine Spath

Head of Preclinical Operations

InCephalo
Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sabine Spath is the Head of Preclinical Operations at InCephalo, Switzerland. Her research interests focus on the immunological mechanisms influencing cancer therapy and intestinal inflammation, as highlighted in her recent articles. Dr. Spath's work explores the roles of various immune cell types and molecular pathways in conditions such as glioblastoma and autoimmune diseases.

Articles (5)

Year:

2025

Year:

2024

Year:

2024

Differing from the mouse Foxp3 gene that encodes only one protein product, human FOXP3 encodes two major isoforms through alternative splicing—a longer isoform (FOXP3 FL) containing all the coding exons and a shorter isoform lacking the amino acids encoded by exon 2 (FOXP3 ΔE2). The two isoforms are naturally expressed in humans, yet their differences in controlling regulatory T cell phenotype and functionality remain unclear. In this study, we show that patients expressing only the shorter isoform fail to maintain self-tolerance and develop immunodeficiency, polyendocrinopathy, and enteropathy X-linked (IPEX) syndrome. Mice with Foxp3 exon 2 deletion have excessive follicular helper T (T FH ) and germinal center B (GC B) cell responses, and develop systemic autoimmune disease with anti-dsDNA and antinuclear autoantibody production, as well as immune complex glomerulonephritis. Despite having normal suppressive function in in vitro assays, regulatory T cells expressing FOXP3 ΔE2 are unstable and sufficient to induce autoimmunity when transferred into Tcrb -deficient mice. Mechanistically, the FOXP3 ΔE2 isoform allows increased expression of selected cytokines, but decreased expression of a set of positive regulators of Foxp3 without altered binding to these gene loci. These findings uncover indispensable functions of the FOXP3 exon 2 region, highlighting a role in regulating a transcriptional program that maintains T reg stability and immune homeostasis.

Year:

2022

Year:

2022

Collaborators (6)

Johannes vom Berg

University of Zurich

SWITZERLAND
View details

Steven Ziegler

-

UNITED STATES
View details

Jack Rohrer

Group Leader/Full Professor

Zurich University of Applied Sciences (ZHAW)

SWITZERLAND
View details

Gregor Hutter

-

SWITZERLAND
View details

Baohua Zhou

Indiana University School of Medicine

UNITED STATES
View details

Phillip Domeier

Assistant Professor

The University of British Columbia

CANADA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.